◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Lifeist Wellness Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Aug 31, 2025 Q2 2025May 31, 2025 Q1 2025Feb 28, 2025 Q4 2024Nov 30, 2024 Q3 2024Aug 31, 2024 Q2 2024May 31, 2024
Total Revenue 32,755 64,689 73,633 -9.6M 130,051 --
Operating Revenue 32,755 64,689 73,633 -11.2M 130,051 --
Cost Of Revenue 9,879 17,048 53,135 -4.6M 35,199 --
Gross Profit 22,876 47,641 20,498 -5.0M 94,852 --
Selling General And Administration 458,601 834,696 649,551 -2.9M 1.9M --
General And Administrative Expense 313,305 675,655 495,513 -1.5M 1.8M --
Research And Development -- -- -- -- 0.00 0.00
Depreciation And Amortization In Income Statement 1,879 2,369 2,747 -75,293 12,610 --
Operating Expense 460,480 837,065 652,298 -3.0M 1.9M --
Operating Income -437,604 -789,424 -631,800 -2.0M -1.8M --
EBIT -591,409 -859,469 -1.4M -1.3M -1.8M --
Interest Expense 0.00 0.00 4,203 -14,983 6,511 --
Interest Expense Non Operating 0.00 0.00 4,203 -14,983 6,511 --
Interest Income 3,533 15,579 14,498 23,148 17,585 --
Interest Income Non Operating 3,533 15,579 14,498 23,148 17,585 --
Net Interest Income 3,533 15,579 10,295 38,131 11,074 --
Other Income Expense -157,338 -85,624 -743,116 682,182 -37,140 --
Other Non Operating Income Expenses -53,901 -- -- -784.00 99,997 -24,999
Special Income Charges -- -- -- 290,000 -50,000 -240,000
Restructuring And Mergern Acquisition -- -- -- -290,000 50,000 240,000
Gain On Sale Of Security -103,437 -85,624 -743,116 392,966 -137,137 --
Pretax Income -591,409 -859,469 -1.4M -1.3M -1.8M --
Tax Provision -- -- -- 0.00 0.00 33,909
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation 600,429 -859,469 -1.4M -42,425 -2.9M --
Net Income From Continuing Operation Net Minority Interest 600,429 -859,469 -1.4M -1.3M 1.8M --
Net Income Including Noncontrolling Interests 600,429 -859,469 -1.4M -42,426 -2.9M --
Net Income Common Stockholders 600,429 -859,469 -1.4M -42,425 -2.9M --
Net Income 600,429 -859,469 -1.4M -42,425 -2.9M --
EBITDA -589,530 -857,100 -1.4M -1.4M -1.7M --
Normalized EBITDA -486,093 -771,476 -614,555 -2.0M -1.6M --
Reconciled Depreciation 1,879 2,369 2,747 -179,508 52,610 --
Basic EPS -0.02 -0.02 -0.04 -- 0.10 -0.06
Diluted EPS -0.02 -0.02 -0.04 -- 0.10 -0.06
Basic Average Shares 37.9M 37.9M 37.9M -- 30.4M 29.2M
Diluted Average Shares 37.9M 37.9M 37.9M -- 30.4M 29.2M
Total Unusual Items -103,437 -85,624 -743,116 682,966 -137,137 --
Total Unusual Items Excluding Goodwill -103,437 -85,624 -743,116 682,966 -137,137 --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income 703,866 -773,845 -621,505 -2.0M 1.9M --
Depreciation Amortization Depletion Income Statement 1,879 2,369 2,747 -75,293 12,610 --
Depreciation Income Statement 1,879 2,369 2,747 -75,293 12,610 --
Diluted NI Availto Com Stockholders 600,429 -859,469 -1.4M -42,425 -2.9M --
Excise Taxes -- -- -- -- 842,497 777,350
Net Income Continuous Operations 600,429 -859,469 -1.4M -1.3M 1.8M --
Net Income Discontinuous Operations 0.00 0.00 0.00 1.2M -4.7M --
Net Non Operating Interest Income Expense 3,533 15,579 10,295 38,131 11,074 --
Other Gand A 179,607 334,252 257,791 -264,468 939,137 --
Reconciled Cost Of Revenue 9,879 17,048 53,135 -4.6M 35,199 --
Salaries And Wages 133,698 341,403 237,722 -1.2M 863,279 --
Selling And Marketing Expense 145,296 159,041 154,038 -1.4M 60,308 --
Total Expenses 470,359 854,113 705,433 -7.6M 1.9M --
Total Other Finance Cost -- -- -- -- -- 35,929
Line Item Q3 2025Aug 31, 2025 Q2 2025May 31, 2025 Q1 2025Feb 28, 2025 Q4 2024Nov 30, 2024 Q3 2024Aug 31, 2024 Q2 2024May 31, 2024
Cash And Cash Equivalents 553,657 973,355 1.6M 2.3M 1.0M --
Cash Cash Equivalents And Short Term Investments 553,657 973,355 1.6M 2.3M 1.0M --
Accounts Receivable 13,100 18,474 89,557 91,856 1.1M --
Receivables 609,316 597,606 705,487 1.2M 997,840 --
Inventory 276,751 291,533 58,076 80,438 1.4M --
Prepaid Assets 68,659 -- -- 47,721 -- 417,122
Other Current Assets -- 134,263 402,816 -- 267,602 --
Current Assets 1.5M 2.0M 2.8M 3.6M 3.7M --
Gross PPE 23,104 36,250 529,668 529,668 2.9M --
Accumulated Depreciation -22,690 -33,957 -525,006 -522,259 -2.5M --
Net PPE 414.00 2,293 4,662 7,409 341,715 --
Goodwill -- -- -- 0.00 0.00 417,091
Goodwill And Other Intangible Assets 110,000 110,000 110,000 110,000 1.3M --
Other Intangible Assets 110,000 110,000 110,000 110,000 1.3M --
Investments And Advances 378,235 482,649 568,498 1.4M 731,506 --
Other Non Current Assets -- -- -- -- 20,798 --
Total Non Current Assets 488,649 594,942 683,160 1.5M 2.4M --
Total Assets 2.0M 2.6M 3.5M 5.1M 6.1M --
Current Debt And Capital Lease Obligation -- -- -- -- 105,392 297,867
Accounts Payable 143,216 153,416 738,213 178,874 -- 2.7M
Payables 143,216 153,416 738,213 178,874 -- 2.7M
Payables And Accrued Expenses 705,699 699,426 738,213 1.0M 2.4M --
Current Accrued Expenses 562,483 546,010 -- 869,456 -- 6.1M
Current Deferred Revenue 2,838 5,676 6,564 12,649 11,254 --
Other Current Liabilities -1.00 -- -- -- -- --
Current Liabilities 708,536 705,102 744,777 1.1M 2.6M --
Long Term Debt And Capital Lease Obligation -- -- -- 0.00 228,957 796,839
Long Term Capital Lease Obligation -- -- -- 0.00 228,957 796,839
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 228,957 --
Total Liabilities Net Minority Interest 708,536 705,102 744,777 1.1M 2.8M --
Common Stock 161.4M 161.4M 161.4M 161.4M 161.2M --
Capital Stock 161.4M 161.4M 161.4M 161.4M 161.2M --
Additional Paid In Capital -- -- 53.0M 53.0M 53.1M 51.8M
Retained Earnings -214.8M -214.2M -213.3M -211.9M -212.2M --
Gains Losses Not Affecting Retained Earnings 54.7M 54.7M -183,495 -183,495 -536,890 --
Other Equity Adjustments 54.7M 54.7M -183,495 -183,495 -536,890 --
Common Stock Equity 1.3M 1.9M 2.7M 4.1M 3.3M --
Stockholders Equity 1.3M 1.9M 2.7M 4.1M 3.3M --
Total Equity Gross Minority Interest 1.3M 1.9M 2.7M 4.1M 3.3M --
Total Capitalization 1.3M 1.9M 2.7M 4.1M 3.3M --
Net Tangible Assets 1.2M 1.8M 2.6M 4.0M 2.0M --
Tangible Book Value 1.2M 1.8M 2.6M 4.0M 2.0M --
Working Capital 799,847 1.3M 2.0M 2.6M 1.1M --
Invested Capital 1.3M 1.9M 2.7M 4.1M 3.3M --
Total Debt -- -- -- 0.00 334,349 1.1M
Share Issued 37.9M 37.9M 37.9M 37.9M 35.9M --
Ordinary Shares Number 37.9M 37.9M 37.9M 37.9M 35.9M --
Available For Sale Securities 4,310 4,310 4,310 4,310 7,635 --
Capital Lease Obligations -- -- -- 0.00 334,349 1.1M
Current Capital Lease Obligation -- -- -- 0.00 105,392 297,867
Current Deferred Liabilities 2,838 5,676 6,564 12,649 11,254 --
Financial Assets Designatedas Fair Value Through Profitor Loss Total 373,925 478,339 564,188 1.4M 723,871 --
Finished Goods -- -- -- 0.00 871,580 1.0M
Investmentin Financial Assets 378,235 482,649 568,498 1.4M 731,506 --
Leases 0.00 0.00 42,243 42,243 1.1M --
Loans Receivable 520,937 520,937 612,677 1.1M -- --
Machinery Furniture Equipment 23,104 36,250 487,425 487,425 1.2M --
Non Current Deferred Assets -- -- -- 0.00 0.00 134,431
Non Current Deferred Taxes Assets -- -- -- 0.00 0.00 134,431
Non Current Prepaid Assets -- -- -- 0.00 -- 28,149
Other Equity Interest -- -- 1.8M 1.8M 1.7M 2.9M
Other Inventories 25,926 11,728 11,727 11,728 245,772 --
Other Properties -- -- -- -- 535,374 1.5M
Other Receivables 3,249 3,249 3,250 3,249 23,411 --
Properties 0.00 0.00 0.00 0.00 0.00 --
Raw Materials 250,825 279,805 46,349 68,710 291,767 --
Taxes Receivable 72,030 54,946 3.00 3.00 -117,567 --
Line Item Q3 2025Aug 31, 2025 Q2 2025May 31, 2025 Q1 2025Feb 28, 2025 Q4 2024Nov 30, 2024 Q3 2024Aug 31, 2024 Q2 2024May 31, 2024
Operating Cash Flow -418,721 -778,104 -1.3M -586,494 -1.1M --
Cash Flow From Continuing Operating Activities -418,721 -778,103 -1.3M -8.0M 6.1M --
Depreciation And Amortization 1,879 2,369 2,747 -179,508 52,610 --
Depreciation Amortization Depletion 1,879 2,369 2,747 -179,508 52,610 --
Stock Based Compensation 2,328 38,199 0.00 -490,498 550,909 --
Deferred Tax -- -- -- 0.00 1,439 -3,587
Deferred Income Tax -- -- -- 0.00 1,439 -3,587
Change In Working Capital 72,110 3,301 -649,336 -6.7M 4.7M --
Change In Receivables -11,710 7,880 -401.00 -1.7M 2.2M --
Change In Inventory 14,782 -233,457 22,362 -5.2M 3.3M --
Change In Payables And Accrued Expense 6,272 -38,787 -310,117 -87,554 -708,261 --
Change In Other Working Capital -2,838 -888.00 -6,085 305,682 -236,037 --
Other Non Cash Items -- -- 1.00 4.4M -4.5M 515,189
Capital Expenditure -- -- -- -- -- -124.00
Purchase Of PPE -- -- -- 0.00 2,769 -124.00
Net PPE Purchase And Sale -- -- -- 0.00 2,769 -124.00
Sale Of Business 0.00 48,127 73,353 -- 0.00 0.00
Sale Of Investment -- -- -- -- 0.00 --
Net Investment Purchase And Sale -- -- -- -- 0.00 --
Investing Cash Flow 0.00 148,127 523,353 1.9M 0.00 --
Cash Flow From Continuing Investing Activities 0.00 148,127 523,353 1.9M 0.00 --
Repayment Of Debt -- -- -- -- 29,130 -90,928
Net Issuance Payments Of Debt -- -- -- 191,072 29,130 -90,928
Issuance Of Capital Stock -- -- -- 0.00 0.00 0.00
Net Common Stock Issuance -- -- -- 0.00 0.00 0.00
Financing Cash Flow 0.00 0.00 0.00 2,989 29,130 --
Cash Flow From Continuing Financing Activities -- -- 0.00 191,072 29,130 -67,435
Effect Of Exchange Rate Changes -977.00 227.00 5,826 17,001 7,742 --
Changes In Cash -418,721 -629,977 -744,741 1.3M -1.1M --
Beginning Cash Position 973,355 1.6M 2.3M 1.0M 2.1M --
End Cash Position 553,657 973,355 1.6M 2.3M 1.0M --
Free Cash Flow -418,721 -778,104 -1.3M -586,494 -1.1M --
Cash From Discontinued Financing Activities 0.00 0.00 0.00 -- 29,130 -90,928
Cash From Discontinued Investing Activities 0.00 0.00 0.00 -- 0.00 -124.00
Cash From Discontinued Operating Activities 0.00 0.00 0.00 7.4M -6.6M --
Change In Prepaid Assets 65,604 268,553 -355,095 -21,968 115,098 --
Common Stock Issuance -- -- -- 0.00 0.00 0.00
Depreciation 1,879 2,369 2,747 -179,508 52,610 --
Gain Loss On Investment Securities -- -- 48,128 -- -- --
Long Term Debt Payments -- -- -- -- 29,130 -90,928
Net Business Purchase And Sale 0.00 48,127 73,353 -- 0.00 0.00
Net Foreign Currency Exchange Gain Loss 977.00 -225.00 -5,828 27,946 34,689 --
Net Income From Continuing Operations -600,429 -859,469 -1.4M -2.7M 624,311 --
Net Long Term Debt Issuance -- -- -- 191,072 29,130 -90,928
Net Other Investing Changes 0.00 100,000 450,000 -- -- --
Operating Gains Losses 977.00 -48,353 42,300 -- 34,689 -17,510
Proceeds From Stock Option Exercised -- -- -- 0.00 0.00 0.00
Unrealized Gain Loss On Investment Securities 104,414 85,850 700,815 -428,659 102,448 --
NEWS
Loading news...
TRENDING
Loading...